Search Results 61-70 of 14767 for anti-TNF drugs

1. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

   Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667. View PubMed; Katz S, Kane SV. Myths and Misconceptions in the ...

2. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

   NSAIDs — If your symptoms are mild, nonsteroidal anti ... Disease-modifying antirheumatic drugs (DMARDs) — These drugs ... TNF-alpha inhibitors block this substance ...

3. Microscopic colitis - Diagnosis and treatment - Mayo Clinic

   Biologic medicines, such as infliximab (Remicade), adalimumab (Humira) or vedolizumab (Entyvio). These can reduce swelling and irritation in the colon. Surgery.

4. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

5. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

   Intolerance, loss response or failure to respond to treatment with at least one TNF-inhibitor within the previous 5 years; Washout of anti-TNF therapy for at ...

6. A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors - Mayo Clinic

   Previous treatment with tocilizumab or etanercept. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

7. Sarcoidosis - Diagnosis and treatment - Mayo Clinic

   Medications · Corticosteroids. These powerful anti-inflammatory drugs are usually the first line treatment for sarcoidosis. · Medications that suppress the immune ...

8. COVID-19 drugs: Are there any that work? - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...

9. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

   ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...

10. Infliximab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of ...